1. Home
  2. WATT vs CLRB Comparison

WATT vs CLRB Comparison

Compare WATT & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Energous Corporation

WATT

Energous Corporation

HOLD

Current Price

$5.97

Market Cap

13.4M

Sector

Technology

ML Signal

HOLD

Logo Cellectar Biosciences Inc.

CLRB

Cellectar Biosciences Inc.

HOLD

Current Price

$3.98

Market Cap

12.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WATT
CLRB
Founded
2012
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.4M
12.8M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
WATT
CLRB
Price
$5.97
$3.98
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
45.5K
59.6K
Earning Date
11-12-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,018,000.00
N/A
Revenue This Year
$509.64
N/A
Revenue Next Year
$210.44
N/A
P/E Ratio
N/A
N/A
Revenue Growth
600.23
N/A
52 Week Low
$3.67
$2.71
52 Week High
$81.00
$41.70

Technical Indicators

Market Signals
Indicator
WATT
CLRB
Relative Strength Index (RSI) 39.72 61.42
Support Level $5.92 $3.30
Resistance Level $6.77 $3.15
Average True Range (ATR) 0.50 0.27
MACD 0.03 0.14
Stochastic Oscillator 14.18 97.94

Price Performance

Historical Comparison
WATT
CLRB

About WATT Energous Corporation

Energous Corp has developed wireless power networks technology (WPNT), consisting of semiconductor chipsets, software controls, hardware designs, and antennas, that enable radio frequency (RF) based charging for Internet of Things (IoT) devices. The WPN technology provides a comprehensive suite of capabilities designed to power the next generation of wireless energy networks, seamlessly delivering power and data across diverse, battery-free device ecosystems. It enhances operational visibility, control, and intelligent business automation. Its products include Transmitter IC & Module, Receivers IC, Transmitter System, and Evaluation Kits.

About CLRB Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

Share on Social Networks: